Search PubMed⌕ Search

Biomedical subjects

H Levison

Publications and source records attributed to H Levison.

At least 91 records · Page 5Linked to original sources

Aerosols--therapeutic use and delivery in childhood asthma.

Aerosol therapy has dramatically improved the lifestyle of the children with asthma, reflecting both the availability of more effective and safer drugs and alternative methods for their delivery. Inhaled treatment with bronchodilators, cromolyn, and inhaled corticosteroids, used singly or in various drug combinations, can control all but the most intractable asthmatic. It is essential that the inhalational device prescribed is appropriate for the child's age and that careful instructions are given as to optimal inhalation technique. Infants and young children with asthma should be given a trial of inhaled bronchodilators, recognizing the limitations this treatment may have in this age group.

Administration, Inhalation↗

Allergic bronchopulmonary aspergillosis in cystic fibrosis: a secretory immune response to a colonizing organism.

One hundred and seventeen patients with cystic fibrosis (CF) were evaluated for criteria suggestive of allergic bronchopulmonary aspergillosis (ABPA) and atopy. We found positive skin tests to Aspergillus to be more common in patients with CF than comparison groups with asthma or non-specific nasal symptoms. This increased prick skin test reactivity to Aspergillus was especially noticeable in a group of CF patients having only one or two skin tests positive, preponderantly Aspergillus. Twelve of the CF patients (10%) had further immunologic criteria suggestive of ABPA. These patients had significantly worse lung function than the CF patients without such criteria.

Adolescent↗

Immediate and delayed bronchoconstriction after exercise in patients with asthma.

Although an immediate asthmatic response after exercise is known to occur in some patients with asthma, the existence of a delayed asthmatic response after exercise is controversial. Accordingly, we studied 53 patients who had an immediate mean (+/- SD) decrease in forced expiratory volume at one second (FEV1) of 36 +/- 13 percent, which was maximal 13 +/- 12 minutes after the completion of treadmill exercise. Eight of these patients also had a delayed asthmatic response (a 32 +/- 5 percent decrease in FEV1 occurring 5.0 +/- 1.8 hours after exercise). During a control day, on which the FEV1 was measured serially but no exercise was performed, the same delayed asthmatic response was observed in all but one patient. This finding suggests that the delayed asthmatic response observed in these patients after exercise was not specifically related to the performance of exercise. We conclude that in patients who have bronchoconstriction immediately after exercise, a second asthmatic response occurring later after the exercise is uncommon.

Adolescent↗

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.

In a randomised cross-over study 12 patients with antibody deficiency and chronic lung disease received monthly infusions of either 0.6 g/kg or 0.2 g/kg intravenous immunoglobulin for six months, and were then switched to the alternative dose for a further six months. Although the incidence of infections did not differ greatly in the high-dose and low-dose phases, the frequency of acute infection was substantially reduced in those periods when serum IgG was 500 mg/dl or more. Pulmonary function worsened on the low-dose regimen and improved on the high-dose regimen.

Acute Disease↗

Prevalence of abnormalities found by sinus x-rays in childhood asthma: lack of relation to severity of asthma.

We examined the prevalence of abnormalities found by sinus x-rays in patients with asthma. The overall prevalence of abnormalities found was greater in the patients with asthma, 43 of 138 (31.2%), compared to control patients with dental problems, 0 of 50 (p less than 0.001). However, the percent of patients with abnormalities found by sinus x-rays was the same whether the asthma was mild, requiring minimal medication, or severe, requiring multiple medications. The results provide no support for the hypothesis that sinusitis, as detected by abnormalities found by sinus x-rays, aggravates asthma and promotes increased need for medication to control the asthma.

Allergens↗

The role of the methacholine challenge in children with chronic cough.

Thirty-nine male and 35 female subjects, aged 6 to 20 years, with chronic cough were studied with spirometry and standard methacholine (MCH) challenge. The duration of their cough before the MCH challenge ranged from 2 months to 13 years. Their FEV1 ranged 62% to 132% predicted. Thirty-six (49%) patients had a positive MCH challenge. The MCH concentration inhaled to decrease the FEV1 by 20% ranged from 0.55 to 25 mg/ml. Follow-up data (mean 14 months) were available on all 74 patients. Fifty-four patients received asthma medications, and 93% improved in mean 3.6 weeks. At the end of the follow-up, 22 (30%) were asymptomatic, 39 (53%) were improved, and 13 patients (17%) were symptomatic. We were unable to predict bronchial hyperreactivity in this population on the basis of duration of the cough, personal or family history of allergies, or baseline spirometry. Thus, MCH challenge is helpful in evaluating children with chronic cough and in guiding therapy. Follow-up of children with chronic cough is important. Eleven percent of this study population progressed to develop bronchial asthma. Forty percent of these patients, initially doing well, were asymptomatic at the end of the follow-up period.

Adolescent↗

Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.

A prevalence study was undertaken to determine whether aerosol equipment used at home by patients with cystic fibrosis (CF) could provide a reservoir for Pseudomonas aeruginosa or Pseudomonas cepacia. Home maintenance of this equipment was also evaluated for its relationship to contamination. In nine of 36 patients, Pseudomonas species were isolated from one or more pieces of home equipment. Only patients colonized with P. aeruginosa had contaminated equipment. P. aeruginosa was recovered from equipment used by five patients; no P. cepacia was recovered. Aerosolization masks were the most commonly contaminated pieces of equipment (20%), followed by nebulizers (17%), medication syringes (10%), connective tubing (6%), and saline solution (4%). Nebulizers and syringes were significantly more likely to be contaminated if they had been in use for 1 month or longer; nebulizers and masks were more likely to be contaminated if they were cleaned or were rinsed only with tap water after use. We conclude that equipment may serve as a reservoir to reintroduce or perpetuate colonization of some patients with CF, but that contamination of equipment with P. aeruginosa is not common.

Child↗

Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis.

A randomized trial of ceftazidime versus placebo was conducted in patients with cystic fibrosis hospitalized for acute respiratory exacerbations. Patients 12 years of age or older were included if they had mild to moderately severe illness according to the following criteria: erythrocyte sedimentation rate less than or equal to 50 mm/hr and less than three other abnormalities (leukocyte count greater than or equal to 15,000/microliter, pulse greater than or equal to 100 beats/min, respirations greater than or equal to 30/min, or temperature greater than or equal to 38.5 degrees C). In all 16 episodes treated with ceftazidime, the patients were rated improved in comparison with 10 of 12 patients treated with placebo. Three placebo-treated patients dropped out of the study within 3 to 5 days because they wanted antibiotic therapy. None of the 15 placebo-treated patients showed clinical deterioration. There were no significant differences in rate of improvement of symptom score, weight gain, or pulmonary function between the two treatment groups. There was no difference in the course during the 6 to 24 months after the study period. Intravenous antibiotics are not essential in the management of all acute respiratory exacerbations of mild to moderate severity in patients with cystic fibrosis.

Adolescent↗

Evaluation of a sustained-release theophylline product in children with asthma.

The purpose of this study was to determine the dose requirements and dose interval of a sustained-release theophylline sprinkle preparation (Somophyllin-12) necessary to maintain therapeutic serum theophylline concentrations in children with asthma. Eighteen patients aged 3-7 years (subgroup 1) and 21 patients aged 8-12 years (subgroup 2), who had been on continuous theophylline therapy with Somophyllin-12, completed the study. Prior to entry into the study, each patient's dosage of Somophyllin-12 was titrated to achieve predose and peak (4-hour postdose) theophylline levels in the therapeutic range (8-20 mg/L). The patients subsequently had predose and peak serum theophylline levels determined at baseline (week 0) and at weeks 2 and 4 of the study. The majority of children maintained theophylline levels in the therapeutic range throughout the 4-week trial, and t-tests showed no significant change from baseline in mean values of peak, trough, or peak-trough theophylline differences in either patient subgroup at weeks 2 and 4. Nevertheless, some individual patients had considerable variation from baseline in peak and trough theophylline levels at follow-up visits. Dosage requirements standardized for weight were significantly higher in patients in subgroup 1 than in subgroup 2 (21.3 +/- 4.5 mg/kg per day versus 17.5 +/- 4.7 mg/kg per day; p less than 0.05). The majority of the patients required 12-hourly administration of Somophyllin-12, but seven of 39 patients required 8-hour dosing.(ABSTRACT TRUNCATED AT 250 WORDS)

Asthma↗

Grading severity and treatment requirements to control symptoms in asthmatic children and their relationship with airway hyperreactivity to methacholine.

Airway hyperreactivity has been proposed to be an important determinant of severity of asthma and medication needs to control symptoms in adults. In this study we tried to determine if this relationship existed in childhood asthma. One hundred and forty-five asthmatic children aged 6 to 19 years with a positive methacholine (MCH) challenge test and a baseline forced expiratory volume in one second (FEV1) of 56% to 118% predicted were studied. The MCH concentration required to decrease the FEV1 from baseline by 20% (PC20) ranged from 0.1 to 20 mg/mL (geometric mean = 1.85 mg/mL). Asthma symptoms in this population before the study ranged from 2 months to 14 years. They were followed for a mean of 10 months after the MCH challenge and then grouped into four groups according to overall severity of symptoms and treatment needed to control symptoms. The first grade was comprised of patients with intermittent symptoms only, with a respiratory tract infection (URTI), and no medication; grade 2 symptoms were severe enough to require intermittent bronchodilators (BD); grade 3 symptoms were severe enough to require daily BD; and grade 4 symptoms were severe enough to require daily BD and steroids. Geometric means PC20 were significantly different among the four groups when they were analyzed by ANOVA P less than .01. There was, however, marked overlap between the individual levels of PC20 among the four groups. There was no significant difference in mean FEV1, age, sex, or duration of symptoms among the four groups. There was no significant correlation between baseline FEV1 and the degree of airway hyperreactivity.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗

Living with cystic fibrosis: patient, family, and physician realities.

The challenge for patient, family, and healthcare professionals alike is to separate the disease's insidiousness from the potential the patient and family have to enjoy life within the patient's abbreviated life span. We must emphasize that most patients with CF and their families do make a successful psychological adjustment. Simultaneously, parents must fulfill the varied physical and psychological needs of the child. A young adult patient with CF summarizes the patient's task: "Projecting a life goal, living it, having the goal altered by luck and by fate, accomplishing that goal, and then reflecting on what has been done. That is life. That is a life compressed for us; CF is myopic. We cannot look through the long vista of life. That is disappointing, frustrating, and cursed at. We can live now. We can do the best we can. Set goals that fit on our playing field and accomplish them." An emotionally adjusted family makes the patient's task possible. Achieving the goal of adequate adjustment also depends on the physician's having the medical expertise to manage this complex multisystem illness and the ability to make the medical knowledge comprehensible for patient and family.

Age Factors↗

The relationship between airway obstruction and bronchial hyperreactivity in childhood asthma.

We performed a methacholine challenge on 118 asthmatic children to determine the relationship between airway obstruction and the degree of airway hyperreactivity. There was no significant correlation between the baseline forced expiratory volume in one second (FEV1) and the PC20 for methacholine (r = .2, P less than .05). We concluded that airway hyperreactivity in asthmatic children does not increase with increasing airway obstruction.

Adolescent↗

The musculoskeletal manifestations of cystic fibrosis.

Twenty-seven patients with CF and joint complaints were reviewed. Twelve patients had arthritis, 11 had HPO, and four had symptoms of mechanical neck and back pain. We have confirmed the association of CF with an episodic form of arthritis. For the first time, we have reported that a subgroup of these patients later develop persistent synovitis with progressive asymmetric, erosive disease. The etiology of CF arthritis is unclear, but may relate to chronic infection and immune complex mechanisms. CF arthritis can be contrasted with CF induced HPO, which is associated with worse lung disease, a male predominance, and an older mean age of onset of symptoms. Mechanical neck and back pain may relate to an associated scoliosis or kyphosis in CF.

Adolescent↗

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?

Antibiotics are administered to patients with cystic fibrosis to eliminate or suppress sputum bacteria. Aerosol administration is attractive because it delivers antibiotic directly to the site of infection. Effective aerosol administration is compromised by the inefficiency of nebulizers to generate small-particle aerosols, adverse airway reaction to the drug, potential emergence of resistant bacteria, and cost. Studies evaluating aerosol treatment have not always controlled for confounding factors and have used a variety of outcome indicators. Results of controlled studies are contradictory with regard to the beneficial effect of aerosol therapy on pulmonary function, sputum bacterial density, and frequency of hospitalization. Therefore, until additional well-controlled trials are completed, routine aerosol administration of antibiotics in cystic fibrosis is not warranted because of cost, potential side effects, and the propensity to select resistant organisms.

Aerosols↗

Transcutaneous monitoring of oxygenation: what is normal?

We examined 55 infants on 119 occasions, from birth to 6 months, to obtain normal data and to establish guidelines for the management of oxygen-dependent infants with chronic lung disease. Transcutaneous oxygen tension (tcPo2) and saturation (tcSao2) were monitored during four states: awake, feeding, quiet sleep, and active sleep. Lowest values (mean +/- SD) for tcSao2 were recorded in all states during the first week of life: awake 96.2% +/- 2.6%, feeding 91.2% +/- 3.7%, quiet sleep 93.2% +/- 2.9%, and active sleep 92.1% +/- 2.9%. After the first week the results were affected by state rather than age, with differences observed between awake and feeding (P less than 0.0001), awake and asleep (P less than 0.00001), and quiet sleep and active sleep (P less than 0.001). The findings for tcPo2 were less consistent and probably affected by the characteristics of skin. In the first week, values were as follows: awake 83.5 +/- 10.1 mm Hg, feeding 73.4 +/- 10.1 mm Hg, quiet sleep 78.5 +/- 10.9 mm Hg, and active sleep 73.4 +/- 11.4 mm Hg. Subsequently, only the state effect remained, and significant differences existed between awake and feeding (P less than 0.0001) and awake and asleep (P less than 0.00001). We conclude that transcutaneous blood gas measurements are affected by state of the infant.

Eating↗

Evaluation of noninvasive measurements of oxygenation in stable infants.

The accuracy with which transcutaneous measurements of oxygen tension reflect PaO2 in older infants has recently been questioned. We therefore examined the effect of maturation, i.e., age or skinfold thickness, on the accuracy of transcutaneous oxygen tension (PtcO2) and oxygen saturation (StcO2) measurements in 19 infants (age 1 to 61 wk) undergoing elective cardiac catheterization. Twenty-seven simultaneous arterial and transcutaneous measurements revealed a good correlation between PtcO2 and PaO2 (r = .91, slope .77, intercept 3.23 torr). The mean arterial-transcutaneous PO2 difference of 10 torr (range - 15 to 35) was independent of age but was significantly correlated with skinfold thickness (r = .45, p less than .05). There was also a good correlation between StcO2 and SaO2 (r = .95, slope .65, intercept 27.8%). The mean arterial-transcutaneous oxygen saturation of 1.4% (range - 17.3 to 14) was unaffected by age or skinfold thickness. However, neither PtcO2 or StcO2 measurements were accurate in patients with severe hypoxemia; StcO2 consistently overestimated the SaO2 when the SaO2 was below 70%. Thus, in this study the discrepant PtcO2 measurements in older infants were due to increasing skinfold thickness rather than age. PtcO2 monitoring still has an important role in oxygen monitoring and together with StcO2 provides valuable information on oxygenation.

Aging↗